�The majority of drugs that we approve are for rare diseases,� Dr. Makary said, as he outlined the FDA�s new framework for rare disease treatments.
�The majority of drugs that we approve are for rare diseases,� Dr. Makary said, as he outlined the FDA�s new framework for rare disease treatments.
Popular Posts